Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Monoclonal antibody therapy of cancer
    Book Section

    Jurcic, J. G.; Mulford, D. A.; Scheinberg, D. A.
    In Kaufman, H. L.; Wolchok, J. D. (Eds.) General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology (2007)

    Fulltext@MSK | Save
  • CD32B in multiple myeloma and systemic AL-amyloidosis
    Meeting Abstract

    Boruchov, A. M.; Zhou, P.; Olshen, A.; Rankin, C.; Bonvini, E.; Koenig, S.; Fleisher, M.; McKenzie, S.; Maslak, P.; Jhanwar, S.; more...
    Haematologica (2007)

    Fulltext@MSK | Save
  • MUC16 gene up-regulates gene transcripts associated with cisplatin resistance in human ovarian cancer cells
    Meeting Abstract

    Thapi, D.; Rosales, N.; Ma, X.; Kehoe, S. M.; Diaz, J. P.; Spriggs, D. R.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Targeting basal-like breast cancer via purine-scaffold Hsp90 inhibitors
    Meeting Abstract

    Lopes, E. C.; Joungnam, K.; Rondina, A.; Moulick, K.; Chiosis, G.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Selective alpha-particle mediated depletion of tumor vasculature with vascular normalization
    Meeting Abstract

    Jaggi, J. S.; Henke, E.; Seshan, S.; Kappel, B.; Chattopadhyay, D.; May, C.; McDevitt, M. R.; Benezra, R.; Scheinberg, D. A.
    Cancer Research (2007)

    Fulltext@MSK | Save
  • Targeted 'Off-the-Shelf' tumor immunotherapy using allogeneic T-Cell precursors
    Meeting Abstract

    Zakrzewski, J. L.; Suh, D.; Smith, O. M.; King, C.; Goldberg, G. L.; Jenq, R.; Holland, A. M.; Grubin, J.; Lu, S. X.; Cabrera-Perez, J.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Alteration of NK tolerance early post-allogeneic hematopoietic cell transplantation results in NK alloreactivity driven by lack of recipient HLA ligand for donor inhibitory KIR
    Meeting Abstract

    Yu, J.; Chewning, J.; Hsu, K.
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save
  • Patients receiving antipsychotic medications following opioids for pain during hospitalization for hematopoietic stem cell transplantation
    Meeting Abstract

    Weiss, T.; Jakubowski, A.; Reznik, I.; Holland, J.
    Psycho-Oncology (2007)

    Fulltext@MSK | Save
  • Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome, for patients with hepatosplenic T-Cell lymphoma: A single institution experience
    Meeting Abstract

    Voss, M.; Zelenetz, A.; Papadopoulos, E. B.; Weissbrot, H.; Horwitz, S. M.
    Blood (2007)

    Fulltext@MSK | Save
  • Synergy of the purine-scaffold HSP90 inhibitor, PU-H71, with doxorubicin in non-Hodgkin's lymphoma cell lines
    Meeting Abstract

    Varticovski, L.; Wright, M. H.; Caldas-Lopes, E.; Chiosis, G.; Robles, A. I.
    Blood (2007)

    Fulltext@MSK | Save